Clozapine effects on force control in schizophrenic patients

Schizophrenia Research

Volumn 34, Issue 1-2, 1998, Pages 39-48

  Vrtunski, P B ^a,b   Konicki, P E ^a,b   Jaskiw, G E ^a,b   Brescan, D W ^a,b   Kwon, K Y ^a,b   Jurjus, G ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clozapine; Drug induced myoclonus; Motor function; Treatment refractory schizophrenics

Indexed keywords

CLOZAPINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HUMAN; MALE; MOTOR CONTROL; MOTOR PERFORMANCE; MYOCLONUS; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSIES, MYOCLONIC; FEMALE; HUMANS; MALE; PSYCHOMOTOR PERFORMANCE; SCHIZOPHRENIA;

EID: 0032501148     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(98)00087-5     Document Type: Article

References (38)

1. Bak T.H., Mauer M., Schaub R.T., Hellweg R., Reischies F.M. Myoclonus in patients treated with clozapine, a case series. J. Clin. Psychiatry. 56:1995;418-422.
2. Baldessarini R.J., Frankenburg F.R. Clozapine, a novel antipsychotic agent. N. Engl. J. Med. 324:1991;746-754.
3. Barak Y., Levine J., Weisz R. Clozapine-induced myoclonus, two case reports. J. Clin. Psychiatry. 16:1996;339-340.
4. Bolden C., Cusack R., Richelson E. Clozapine is a potent and selective muscarinic antagonist at the five cloned human muscarinic acetylcholine receptors expressed in the CHO-K 1 cell. Eur. J. Pharmacol. 192:1991;205-206.
5. Brescan D.W., Ramirez L.F., Jaskiw G.E., Konicki P.E., Vrtunski P.B. Effects of clozapine and risperidone on force control [Abstract]. Schizophr. Res. 24:1997;264.
6. Davis, J., 1985. Antipsychotic drugs. In: Kaplan, H., Sadock, B. (Eds.), Comprehensive Textbook of Psychiatry, Vol. 2. Baltimore, Williams & Wilkins, pp. 1481-1512.
7. Dawson G.D. Investigations on a patient subject to myoclonic seizures after sensory stimulation. J. Neurol. Neurosurg. Psychiatry. 10:1947;141-162.
8. Denney D., Stevens J.R. Clozapine and seizures. Biol. Psychiatry. 37:1995;427-433.
9. Devinsky O., Honigfeld G., Patin J. Clozapine-related seizures. Neurology. 41:1991;369-371.
10. Haller E., Binder R. Clozapine and seizures. Am. J. Psychiatry. 147:1994;1069-1071.
11. Hallett M. Is dystonia a sensory disorder? Neurology. 38:1995;139-140.
12. Halliday A.M. The electrophysiological study of myoclonus in man. Brain. 90:1967;241-284.
13. Henneman E. Relation between size of neurons and their susceptibility to discharge. Science. 126:1957;1345-1346.
14. Henneman, E., 1980. Organization of the motoneuron pool: The size principle. In: Mountcastle, V.B. (Ed.), Medical Physiology, Vol. I. Mosby, St. Louis, MO, pp. 718-741.
15. Henneman, E., 1981. Recruitment of motoneurons: The size principle. In: Desmedt, J.E. (Ed.), Progress in Clinical Neurophysiology. Vol. 9. Motor Unit Types, Recruitment and Plasticity in Health and Disease. Karger, Basel, pp. 26-60.
16. Henneman, E., 1990. Comments on the logical basis of muscle control. In: Binder, M.D., Mendell, L.M. (Eds.), The Segmental Motor System. Oxford University Press, New York, pp. vii-x.
17. Kane J., Honigfeld G., Singer J., Meltzer H. Clozapine for the treatment-resistant schizophrenic, a double-blind comparison with chlorpromazine. Arch. Gen. Psychiatry. 45:1988;789-796.
18. Keegan D. Risperidone, neurochemical, pharmacological and clinical properties of a new antipsychotic drug. Can. J. Psychiatry. 39((Suppl. 2)):1994;S46-S52.
19. Konicki E.P., Brescan D.W., Fuller M.A., Jaskiw G.E., Jurjus G., Kwon K.Y.et al. Effect of antipsychotic drugs on force control in schizophrenics [Abstract]. Soc. Neurosci. Abstr. 22:1996;240.
20. Koukkou M., Angst J., Zimmer D. Paroximal EEG activity and psychopathology during the treatment with clozapine. Pharmacopsychiatry. 12:1979;173-183.
21. Malow B.A., Reese K.B., Sato S., Bogard P.J., Malhotra A.K., Su T.P.et al. Spectrum of EEG abnormalities during clozapine treatment. J. Electroencephal. Clin. Neurophys. 91:1994;205-211.
22. Marsden, C.D., Rothwell, J.C., 1985. Abnormal feedback and movement disorders in man, with particular reference to cortical myoclonus. In: Barnes, W.J.P., Gladden, M.H. (Eds.), Feedback and Motor Control in Invertebrates and Vertebrates. Croom Helm, London, pp. 465-475.
23. Meltzer H.Y., Stockmeier C.A. In vivo occupancy of dopamine receptors by antipsychotic drugs. Arch. Gen. Psychiatry. 49:1992;588-589.
24. National Institute of Mental Health, 1976. Abnormal Involuntary Movement Scale. In: Guy, W. (Ed.), ECDEU Assessment Manual. US Department of HEW, Rockville, MD, pp. 534-537.
25. Obeso J.A., Rothwell J.C., Marsden C.D. The spectrum of cortical myoclonus. Brain. 108:1985;193-224.
26. Oldfield R.C. The assessment and analysis of handedness. The Edinburgh Inventory. Neuropsychologia. 9:1971;97-113.
27. Pickar D., Owen R.R., Litman R.E., Konicki P.E., Gutierrez R., Rapaport M.H. Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine. Arch. Gen. Psychiatry. 49:1992;345-353.
28. Safferman A., Lieberman J.A., Kane J.M., Szymanski S., Kinon B. Update on the clinical efficacy and side effects of clozapine. Schizophr. Bull. 17:1991;247-261.
29. Sajatovic M., Meltzer H.Y. Clozapine-induced myoclonus and generalized seizures. Biol. Psychiatry. 39:1996;367-370.
30. Schooler N.R., Kane J.M. Research diagnoses for tardive dyskinesia. Arch. Gen. Psychiatry. 39:1982;486-487.
31. Simpson G.M., Angus J.W.S. A rating scale for extrapyramidal side effects. Acta Psychiatrica Scand. 212:1970;11-19.
32. Terao Y., Ugawa Y., Hanajima R., Yumoto M., Kawahara Y., Yamamoto T.et al. Motor cortical reflex myoclonus, a case study with MEG. J. Electroencephal. Clin. Neurophys. 102:1997;505-511.
33. Van Tol H.H., Bunzow J.R., Guan H.C., Sunahara R.K., Seeman P., Niznik H.B.et al. Cloning of the gene for a human D4 receptor with high affinity for the antipsychotic clozapine. Nature. 350:1991;610-614.
34. Vrtunski P.B., Alphs L.D., Meltzer H.Y. Isometric force control in schizophrenic patients with tardive dyskinesia. Psychiatry Res. 37:1991;57-72.
35. Vrtunski P.B., Lewis K.L., Meltzer H.Y. Visual feedback in force control of schizophrenics. Biol. Psychiatry. 34:1993;667-670.
36. Vrtunski P.B., Alphs L.D., Meltzer H.Y. Motor mechanisms in schizophrenic patients with tardive dyskinesia. Psychiatry Res. 54:1994;71-86.
37. Vrtunski P.B., Konicki P.E., Kwon K.Y., Jurjus G., Jaskiw G.E. Effect of clozapine on motor function in schizophrenic patients. Schizophr. Res. 20:1996;187-198.
38. Wolters E.C.H., Hurwitz T.A., Peppard R.F., Calne D.B. Clozapine, an antipsychotic agent for Parkinson's disease? Clin. Neuropharmacol. 12:1989;83-90.